U.S. Rep. Dusty Johnson: ‘No 340B Savings for Transgender Care Act’ Responds to Drug Industry’s Lies, Clarifies Savings’ Use 

U.S. Rep. Dusty Johnson (R-S.D.) told KSDN News that his “No 340B Savings for Transgender Care Act” responds to drug industry-backed efforts to undermine the 340B program.
The influential sponsor of a GOP U.S. House bill that would prohibit covered entities from using 340B savings on gender-affirming [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Trump-Aligned Think Tank Proposes Lowering U.S. Drug Prices Through IRA and Other Policies, Doesn’t Weigh In on 340B Program

America First Policy Institute released a March 21 brief detailing how policymakers “could accelerate drug development and enhance patient health by implementing reforms that discourage other countries from freeloading off American drug innovation.”
A conservative think tank, which officials who served in President Donald Trump’s (R) first administration founded to advance his priorities, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Senate Committee Confirms Dr. Oz as CMS Administrator in Party-Line Vote, Sends Nomination to Full Chamber

The Senate Finance Committee confirmed Mehmet Oz’s CMS administrator nomination on a 14-13 party-line vote.
A key Senate panel voted along party lines Tuesday afternoon to confirm Mehmet Oz as President Donald Trump’s (R) pick [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Dr. Oz’s Ties to Company that Partners With 340B Hospitals Draws Scrutiny, Senate Panel Prepares Vote on CMS Administrator Nomination

Mehmet Oz, President Donald Trump’s (R) pick to lead the Centers for Medicare & Medicaid Services, drew new scrutiny this week over his ties to a health benefits company that partners with 340B hospitals.
President Donald Trump’s (R) pick of Mehmet Oz to lead the Centers for Medicare & Medicaid Services (CMS) drew new [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

U.S. Senate Bipartisan 340B Working Group Announces New Members, New Mexico Sends Contract Pharmacy Access Bill to Gov.

U.S. Sens. Jerry Moran (R-Kan.), Shelley Moore Capito (R-W.V.) and Tammy Baldwin (D-Wis.) have announced U.S. Sens. Markwayne Mullin (R-Okla.), John Hickenlooper (D-Colo.) and Tim Kaine (D-Va.) as the newest members of the Senate 340B bipartisan working group.
The bipartisan group of six U.S. senators behind long-awaited 340B program overhaul legislation, known as the SUSTAIN 340B Act, is [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Advocate Slams Federal ‘No 340B Savings for Transgender Care Act’ Proposal

Peggy Tighe, a principal at Powers Law, told 340B Report that U.S. Rep. Dusty Johnson’s (R-S.D.) bill "appears to be an attempt to thwart attacks against the 340B program, perhaps to protect GOP state and federal legislators, but it is anti-states' rights and an overreaction to a false and incendiary campaign.”
A 340B program advocate this week condemned a new GOP U.S. House bill that would prohibit covered entities from using [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Vermont House Passes Contract Pharmacy Access Bill, While U.S. House Republican Introduces ‘No 340B Savings for Transgender Care Act’

The Vermont House cleared a 340B contract pharmacy access bill by voice vote, sending it to the state Senate.
The Vermont House of Representatives voted this morning to pass a contract pharmacy access bill, the same day that a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Program Garners National Headlines Over Dark Money Ads, Employer Pharmacy Benefit Plans 

The Associated Press and Wall Street Journal recently published articles that highlighted the 340B program.
The 340B drug pricing program is drawing newfound national media attention following recent articles on a multistate dark money ad [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

CMS Nominee ‘Dr. Oz’ Grilled Over Potential Medicaid Cuts and Position on Medicare Negotiations at Confirmation Hearing 

The Senate Finance Committee pressed Mehmet Oz, known as "Dr. Oz," on whether he would oppose cuts to Medicaid as CMS administrator. Oliver Oz, his son who is marketed as having a leadership role at a 340B services company, sat behind him during the hearing.
Mehmet Oz, President Donald Trump’s (R) nominee to lead the Centers for Medicare & Medicaid Services (CMS), faced persistent questioning—primarily [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Sumitomo, J&J Announce 340B Refunds to Covered Entities

Sumitomo Pharma and Johnson & Johnson announced lists of drugs eligible for refunds.
Two drugmakers recently notified covered entities of adjustments to their 340B drug ceiling prices and resulting refund eligibility. Sumitomo Pharma [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live